Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer

Cell Death and Disease

Volumn 5, Issue 2, 2014, Pages

  Chen, Y ^a   Fu, L L ^a   Wen, X ^a   Wang, X Y ^a   Liu, J ^a   Cheng, Y ^b   Huang, J ^c  

^a SICHUAN UNIVERSITY   (China)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

mitochondria; oncogene; sirtuin 3 (SIRT3); therapeutic target; tumor suppressor

Indexed keywords

JANUS KINASE; SIRTUIN 3;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER INHIBITION; CELL DEATH; CELL STRESS; HUMAN; MITOCHONDRION; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; HUMANS; MITOCHONDRIA; NEOPLASMS; SIRTUIN 3; TUMOR SUPPRESSOR PROTEINS;

EID: 84896756082     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.14     Document Type: Article

References (60)

1. Weir HJ, Lane JD, Balthasar N. SIRT3: A central regulator of mitochondrial adaptation in health and disease. Genes Cancer 2013; 4: 118-124.
2. Hallows WC, Albaugh BN, Denu JM. Where in the cell is SIRT3?-Functional localization of an NAD+-dependent protein deacetylase. Biochem J 2008; 411: E11-e13.
3. Buler M, Aatsinki SM, Izzi V, Hakkola J. Metformin reduces hepatic expression of SIRT3, the mitochondrial deacetylase controlling energy metabolism. PLoS One 2012 e49863.
4. Hallows WC, Lee S, Denu JM. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci USA 2006; 103: 10230-10235.
5. Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CF, Steegborn C. Substrates and regulation mechanisms for the human mito-chondrial sirtuins Sirt3 and Sirt5. J Mol Biol 2008; 382: 790-801.
6. Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci USA 2008; 105 14452.
7. Yang Y, Cimen H, Han MJ, Shi T, Deng JH, Koc H et al. NAD+-dependent deacetylase SIRT3 regulates mito-chondrial protein synthesis by deacetylation of the ribosomal protein MRPL10. J Biol Chem 2010; 285: 7417-7429.
8. Shulga N, Pastorino JG. Ethanol sensitizes mitochondria to the permeability transition by inhibiting deacetylation of cyclophilin-D mediated by sirtuin-3. J Cell Sci 2010; 123 4127.
9. Shi T, Wang F, Stieren E, Tong Q. SIRT3, a mito-chondrial sirtuin deacetylase, regulates mito-chondrial function and thermogenesis in brown adipocytes. J Biol Chem 2005; 280 13567.
10. Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 2009; 119: 2758-2771.
11. Finley LW, Haigis MC. Metabolic regulation by SIRT3: Implications for tumorigenesis. Trends Mol Med 2012; 18: 516-523.
12. Alhazzazi TY, Kamarajan P, Verdin E, Kapila YL. SIRT3 and cancer: Tumor promoter or suppressor? Biochim Biophys Acta 2011; 1816: 80-88.
13. Bruzzone S, Parenti MD, Grozio A, Ballestrero A, Bauer I, Del Rio A et al. Rejuvenating sirtuins: The rise of a new family of cancer drug targets. Curr Pharm Des 2013; 19 623.
14. Nguyen GT, Schaefer S, Gertz M, Weyand M, Steegborn C. Structures of human sirtuin 3 complexes with ADP-ribose and with carba-NAD+ and SRT1720: Binding details and inhibition mechanism. Acta Crystallogr D Biol Crystallogr 2013; 69: 1423-1432.
15. Schwer B, Bunkenborg J, Verdin RO, Andersen JS, Verdin E. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci USA 2006; 103: 10224-10229.
16. Sanders BD, Zhao K, Slama JT, Marmorstein R. Structural basis for nicotinamide inhibition and base exchange in Sir2 enzymes. Mol Cell 2007; 25: 463-472.
17. Wen X, Wu J, Wang F, Liu B, Huang C, Wei Y. Deconvoluting the role of reactive oxygen species and autophagy in human diseases. Free Radic Biol Med 2013; 65C: 402-410.
18. Bause AS, Haigis MC. SIRT3 regulation of mitochondrial oxidative stress. Exp Gerontol 2013; 48: 634-639.
19. Bell EL, Guarente L. The SirT3 divining rod points to oxidative stress. Mol Cell 2011; 42 568.
20. Hirschey MD, Shimazu T, Huang JY, Schwer B, Verdin E. SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harb Symp Quant Biol 2011 267-277.
21. Park SH, Ozden O, Jiang H, Cha YI, Pennington JD, Aykin-Burns N et al. Sirt3, Mitochondrial ROS, Ageing, and Carcinogenesis. Int J Mol Sci 2011; 12: 6226-6239.
22. Haigis MC, Deng CX, Finley LW, Kim HS, Gius D. SIRT3 is a mitochondrial tumor suppressor: A scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis. Cancer Res 2012; 72: 2468-2472.
23. Han C, Someya S. Maintaining good hearing: Calorie restriction, Sirt3, and glutathione. Exp Gerontol 2013; 48: 1091-1095.
24. Opalach K, Rangaraju S, Madorsky I, Leeuwenburgh C, Notterpek L. Lifelong calorie restriction alleviates age-related oxidative damage in peripheral nerves. Rejuvenation Res 2010; 13: 65-74.
25. Hebert AS, Dittenhafer-Reed KE, Yu W, Bailey DJ, Selen ES, Boersma MD et al. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol Cell 2013; 49: 186-199.
26. Onyango P, Celic I, McCaffery JM, Boeke JD, Feinberg AP. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci USA 2002; 99: 13653-13658.
27. Schwer B, North BJ, Frye RA, Ott M, Verdin E. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol 2002; 158: 647-657.
28. Kong X, Wang R, Xue Y, Liu X, Zhang H, Chen Y et al. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One 2010; 5: E11707.
29. Giralt A, Hondares E, Villena JA, Ribas F, Díaz-Delfín J, Giralt M et al. Peroxisome proliferator-Activated receptor-gamma coactivator-1alpha controls transcription of the Sirt3 gene, an essential component of the thermogenic brown adipocyte phenotype. J Biol Chem 2011; 286: 16958-16966.
30. Osborne B, Cooney GJ, Turner N. Are sirtuin deacylase enzymes important modulators of mitochondrial energy metabolism? Biochim Biophys Acta 27August 2013; doi:10.1016/j. bbagen.2013.08.016.
31. Guarente L. Introduction: Sirtuins in aging and diseases. Methods Mol Biol 2013; 1077 10.
32. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144 674.
33. Tao R, Coleman MC, Pennington JD, Ozden O, Park SH, Jiang H et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell 2010; 40: 893-904.
34. Scher MB, Vaquero A, Reinberg D. SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev 2007 920-928.
35. Schumacker PT. SIRT3 controls cancer metabolic reprogramming by regulating ROS and HIF. Cancer Cell 2011; 19: 299-300.
36. Koyama T, Kume S, Koya D, Araki S, Isshiki K, Chin-Kanasaki M et al. SIRT3 attenuates palmitate-induced ROS production and inflammation in proximal tubular cells. Free Radic Biol Med 2011; 51: 1258-1267.
37. McGuinness D, McGuinness DH, McCaul JA, Shiels PG. Sirtuins, bioageing, and cancer. J Aging Res 2011; 2011: 235754.
38. Semenza GL. Hypoxia-inducible factors: Media-Tors of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012; 33: 207-214.
39. Bell EL, Emerling BM, Ricoult SJ, Guarente L. SirT3 suppresses hypoxia inducible factor 1alpha and tumor growth by inhibiting mitochondrial ROS production. Oncogene 2011; 30 2996.
40. Cheng Y, Ren X, Gowda AS, Shan Y, Zhang L, Yuan YS et al. Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress. Cell Death Dis 2013; 4: E731.
41. Alhazzazi TY, Kamarajan P, Verdin E, Kapila YL. Sirtuin-3 (SIRT3) and the Hallmarks of Cancer. Genes Cancer 2013; 4: 164-171.
42. Lai CC, Lin PM, Lin SF, Hsu CH, Lin HC, Hu ML et al. Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumour Biol 2013; 34 1854.
43. Sundaresan NR, Samant SA, Pillai VB, Rajamo-han SB, Gupta MP. SIRT3 is a stress responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku-70. Mol Cell Biol 2008; 28: 6384-6401.
44. Li S, Banck M, Mujtaba S, Zhou MM, Sugrue MM, Walsh MJ. p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase. PLoS One 2010; 5: E10486.
45. Zhang L, Ren X, Cheng Y, Huber-Keener K, Liu X, Zhang Y et al. Identification of Sirtuin 3, a mitochondrial protein deacetylase, as a new contributor to tamoxifen resistance in breast cancer cells. Biochem Pharmacol 2013; 86: 726-733.
46. Zhao Y, Yang H, Wang X, Zhang R, Wang C, Guo Z. Sirtuin-3 (SIRT3) expression is associated with overall survival in esophageal cancer. Ann Diagn Pathol 2013; 17 485.
47. Kamarajan P, Alhazzazi TY, Danciu T, D'silva NJ, Verdin E, Kapila YL. Receptorinteracting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis. Cancer 2012; 118: 5800-5810.
48. Alhazzazi TY, Kamarajan P, Joo N, Huang JY, Verdin E, D'Silva NJ et al. Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer 2011; 117 1678.
49. Li H, Feng Z, Wu W, Li J, Zhang J, Xia T. SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non-small cell lung cancer cells through deacetylation of NMNAT2. Int J Oncol 2013; 43: 1420-1430.
50. Allison SJ, Milner J. SIRT3 is pro-Apoptotic and participates in distinct basal apoptotic pathways. Cell Cycle 2007; 6: 2669-2677.
51. Marfe G, Tafani M, Indelicato M, Sinibaldi-Salimei P, Reali V, Pucci B et al. Kaempferol induces apoptosis in two different cell lines via Akt inactivation, Bax and SIRT3 activation, and mitochondrial dysfunction. J Cell Biochem 2009; 106: 643-650.
52. Finley LW, Carracedo A, Lee J, Souza A, Egia A, Zhang J et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1a destabilization. Cancer Cell 2011; 19: 416-428.
53. Zhang YY, Zhou LM. Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation. Biochem Biophys Res Commun 2012; 423: 26-31.
54. Xiao K, Jiang J, Wang W, Cao S, Zhu L, Zeng H et al. Sirt3 is a tumor suppressor in lung adenocarcinoma cells. Oncol Rep 2013; 30: 1323-1328.
55. Yang B, Fu X, Shao L, Ding Y, Zeng D. Aberrant expression of SIRT3 is conversely correlated with the progression and prognosis of human gastric cancer. Biochem Biophys Res Commun 2014; 443: 156-160.
56. Liu B, Wen X, Cheng Y. Survival or death: Disequilibrating the oncogenic and tumor suppressive autophagy in cancer. Cell Death Dis 2013; 4: E892.
57. Signorelli P, Ghidoni R. Resveratrol as an anticancer nutrient: Molecular basis, open questions and promises. J Nutr Biochem 2005; 16: 449-466.
58. Rayalam S, Yang JY, Ambati S, Della-Fera MA, Baile CA. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother Res 2008; 22 1371.
59. Wei L, Zhou Y, Dai Q, Qiao C, Zhao L, Hui H et al. Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma. Cell Death Dis 2013; 4: E601.
60. Salo HS, Laitinen T, Poso A, Jarho E, Lahtela-Kakkonen M. Identification of novel SIRT3 inhibitor scaffolds by virtual screening. Bioorg Med Chem Lett 2013; 23 2995.